Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Nektar Therapeutics NKTR

Set alert

Price alert · NKTR

All alert types
38.10 USD +1.15 +3.11%

As of Nov 3, 10:23 AM ET

Bid
37.90 × 1
Ask
38.43 × 1
37.28 Day range 38.30
33.40 52-week range 109.00
YTD
-9.89%
1 year
-36.42%
Open
37.28
Prev close
36.95
Mkt cap
1.30B
Vol
55.84K
Avg vol
1.10M
EPS
-18.96
P/E
0.00
Div yield
0.00%
More statistics
Low
37.28
High
38.30
Forward P/E
-3.59
Beta
1.42
Short ratio
3.62
Inst. own
107.23%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
55.69
200-d avg
65.01
1y target
133.08

5D chart

Chart tools
Interval
1m5m15m30m

Signals (115)
NameTimeAgo
SMA: BullishNov 3, 9:30 AM53 minutes ago
SMA: BullishNov 3, 9:30 AM53 minutes ago
MACD: Buy SignalNov 3, 9:30 AM53 minutes ago
SMA: BearishNov 2, 3:50 PM18 hours ago
SMA: BullishNov 2, 3:45 PM18 hours ago
RSI: OversoldNov 2, 3:30 PM18 hours ago
MACD: Sell SignalNov 2, 3:20 PM19 hours ago
SMA: BearishNov 2, 3:10 PM19 hours ago
SMA: BearishNov 2, 2:30 PM19 hours ago
MACD: Buy SignalNov 2, 2:30 PM19 hours ago
SMA: BullishNov 2, 2:25 PM19 hours ago
RSI: OversoldNov 2, 1:40 PM20 hours ago
SMA: BearishNov 2, 1:10 PM21 hours ago
MACD: Sell SignalNov 2, 1:10 PM21 hours ago
SMA: BullishNov 2, 1:05 PM21 hours ago
MACD: Buy SignalNov 2, 1:05 PM21 hours ago
MACD: Sell SignalNov 2, 12:45 PM21 hours ago
MACD: Buy SignalNov 2, 12:40 PM21 hours ago
MACD: Sell SignalNov 2, 12:35 PM21 hours ago
SMA: BearishNov 2, 12:00 PM22 hours ago

Newest 20 of 115.

Analyst view

Consensus: buy

Buy
Price target (mean) 133.08 +249.3% upside
Target (low)
50.00
Target (mean)
133.08
Target (high)
192.00
Ratings (0m) 15 11 buy · 4 hold · 0 sell
  • Strong buy1
  • Buy10
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 12
  • 2 months ago 12

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NKTR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-2.07-3.07 – -1.71-1.87-10.7%10.40M-11.8%15
Next quarter-2.76-3.53 – -2.14-1.78-54.9%10.47M-52.0%15
Current year-8.08-9.63 – -6.89-9.73+16.9%41.82M-24.3%15
Next year-10.50-20.03 – -4.10-8.08-29.9%53.42M+27.7%15

Upgrades and downgrades

The latest rating changes

NKTR analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026UBSInitiated—Neutral
Oct 12, 2026Leerink PartnersInitiated—Outperform
Oct 9, 2026BTIGReiteratedBuyBuy
Oct 9, 2026Raymond JamesInitiated—Market Perform
Oct 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 28, 2026BTIGReiteratedBuyBuy
Sep 25, 2026BTIGReiteratedBuyBuy
Sep 23, 2026WedbushMaintainedNeutralNeutral
Sep 16, 2026BTIGReiteratedBuyBuy
Sep 9, 2026BTIGReiteratedBuyBuy
Jul 22, 2026Canaccord GenuityInitiated—Buy
May 11, 2026WedbushMaintainedNeutralNeutral
May 8, 2026Piper SandlerMaintainedOverweightOverweight
Apr 21, 2026CitigroupMaintainedBuyBuy
Apr 21, 2026WedbushMaintainedNeutralNeutral
Apr 20, 2026HC Wainwright & Co.MaintainedBuyBuy
Apr 20, 2026BTIGMaintainedBuyBuy
Mar 24, 2026WedbushInitiated—Neutral
Mar 17, 2026TD CowenInitiated—Buy
Mar 16, 2026CitigroupMaintainedBuyBuy
Feb 23, 2026B. Riley SecuritiesReiteratedBuyBuy
Feb 10, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 10, 2026BTIGMaintainedBuyBuy
Jan 29, 2026BTIGReiteratedBuyBuy
Dec 16, 2025HC Wainwright & Co.MaintainedBuyBuy
Dec 16, 2025BTIGMaintainedBuyBuy
Nov 26, 2025CitigroupInitiated—Buy
Nov 26, 2025JefferiesMaintainedBuyBuy
Sep 23, 2025B. Riley SecuritiesMaintainedBuyBuy
Sep 19, 2025BTIGReiteratedBuyBuy